Cargando…
Embelin prevents amyloid-beta accumulation via modulation of SOD1 in a Streptozotocin-induced AD-like condition: An evidence from in vitro investigation
Embelin is a neuroprotective compound with therapeutic benefit against experimental Alzheimer's disease (AD)-like condition. In the quest of untangling the underlying mechanism behind the neuroprotective effect of Embelin in AD, an in-vitro study of Embelin against neuronal damage induced by St...
Autores principales: | Bhuvanendran, Saatheeyavaane, Paudel, Yam Nath, Kumari, Yatinesh, Othman, Iekhsan, Shaikh, Mohd. Farooq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743048/ https://www.ncbi.nlm.nih.gov/pubmed/36518345 http://dx.doi.org/10.1016/j.crneur.2022.100032 |
Ejemplares similares
-
Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a Rat Model
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2018) -
Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review
por: Kundap, Uday P., et al.
Publicado: (2017) -
Embelin Improves the Spatial Memory and Hippocampal Long-Term Potentiation in a Rat Model of Chronic Cerebral Hypoperfusion
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2019) -
Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model
por: Kundap, Uday Praful, et al.
Publicado: (2019) -
Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies
por: Bhuvanendran, Saatheeyavaane, et al.
Publicado: (2019)